Home
News
Videos
Podcasts
Menu
Акционерное общество "ТВ БРИКС"
tvbrics@tvbrics.com
Рубцов переулок, д.13, Москва, 105082, RU
+74996425304
Currencies:
RUB/USD 0,0119
BRL/USD 0,1956
0,0015
INR/USD 0,0104
CNY/USD 0,149
0,0002
ZAR/USD 0,0612
0,0002
IDR/USD 0,0001
SPACE FOR MEDIA DIPLOMACY
20:00 «Russian Lessons with Tanya Semke»
20:00 «Russian Lessons with Tanya Semke»
Now 16+
20:00

«Russian Lessons with Tanya Semke»

It is indicated Moscow time in the programme. Please take into account the time difference with your time zone.
20:15 «Laboratorium»
Next
20:15

«Laboratorium»

16+
20:30

«Lеt's be clear»

16+
21:00

«BRICSreport»

16+
Menu
Broadcast «Russian Lessons with Tanya Semke»
RUB/USD
0,0119
BRL/USD
0,1956
0,0015
INR/USD
0,0104
CNY/USD
0,149
0,0002
ZAR/USD
0,0612
0,0002
IDR/USD
0,0001
TV BRICS Apps

Iran among world’s top ten nations in nuclear medicine use

Country strengthens domestic production of radiopharmaceuticals for diagnosis and treatment

Iran has positioned itself among the world’s top ten countries in the use of radiopharmaceuticals for medical diagnosis and treatment, according to Dr Ramazan Ahadi, a member of the Board of Directors of the Iranian Society of Nuclear Medicine. 

Speaking at a pharmaceutical industry exhibition, Ahadi explained that radiopharmaceuticals play a vital role in modern medicine, helping to diagnose and treat a range of illnesses with greater precision. This was reported by Mehr News Agency, a partner of TV BRICS.

He noted that the use of radiopharmaceuticals is growing worldwide as countries adopt nuclear medicine technologies to enhance healthcare outcomes. Iran, he added, has made major strides in localising production, allowing it to meet domestic demand and reduce reliance on imports.

"Currently, around 400 medical centres across the country use domestically produced radiopharmaceuticals to treat patients", Ahadi said, describing the field as one of the most significant advances in nuclear medicine and an area of increasing global collaboration and innovation.

Photo: Creativebird / iStock